Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status

Detalles Bibliográficos
Autores principales: Cheung, Ka Shing, Ka, Lam Lok, Leung, Wai K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982343/
https://www.ncbi.nlm.nih.gov/pubmed/36872925
http://dx.doi.org/10.1159/000528824
_version_ 1784900310893854720
author Cheung, Ka Shing
Ka, Lam Lok
Leung, Wai K.
author_facet Cheung, Ka Shing
Ka, Lam Lok
Leung, Wai K.
author_sort Cheung, Ka Shing
collection PubMed
description
format Online
Article
Text
id pubmed-9982343
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-99823432023-03-04 Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status Cheung, Ka Shing Ka, Lam Lok Leung, Wai K. Liver Cancer Reply S. Karger AG 2022-12-29 /pmc/articles/PMC9982343/ /pubmed/36872925 http://dx.doi.org/10.1159/000528824 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
spellingShingle Reply
Cheung, Ka Shing
Ka, Lam Lok
Leung, Wai K.
Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
title Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
title_full Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
title_fullStr Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
title_full_unstemmed Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
title_short Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
title_sort antibiotics associated with lower survival in hepatocellular cancer patients receiving immune checkpoint inhibitors independent of tumor status
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982343/
https://www.ncbi.nlm.nih.gov/pubmed/36872925
http://dx.doi.org/10.1159/000528824
work_keys_str_mv AT cheungkashing antibioticsassociatedwithlowersurvivalinhepatocellularcancerpatientsreceivingimmunecheckpointinhibitorsindependentoftumorstatus
AT kalamlok antibioticsassociatedwithlowersurvivalinhepatocellularcancerpatientsreceivingimmunecheckpointinhibitorsindependentoftumorstatus
AT leungwaik antibioticsassociatedwithlowersurvivalinhepatocellularcancerpatientsreceivingimmunecheckpointinhibitorsindependentoftumorstatus

Ejemplares similares